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Abstract SecA is the central component of the protein-
translocation machinery of Escherichia coli. It is able to interact
with the precursor protein, the chaperone SecB, the integral
membrane protein complex SecYEG, acidic phospholipids and its
own mRNA. We studied the interaction between prePhoE and
SecA by using a site-specific photocrosslinking strategy. We
found that SecA is able to interact with both the signal sequence
and the mature domain of prePhoE. Furthermore, this interac-
tion was dependent on the type of nucleotide bound. SecA in the
ADP-bound conformation was unable to crosslink with the
precursor, whereas the ATP-bound conformation was active in
precursor crosslinking. The SecA^precursor interaction was
maintained in the presence of E. coli phospholipids but was
loosened by the presence of phosphatidylglycerol bilayers.
Examining SecA ATP binding site mutants demonstrated
that ATP hydrolysis at the N-terminal high affinity binding
site is responsible for the changed interaction with the pre-
protein. ß 2000 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Many proteins destined for the periplasm or outer mem-
brane of Escherichia coli are transported across the inner
membrane by a multicomponent protein complex called pre-
protein translocase [1]. This machinery also catalyzes insertion
of some proteins into the inner membrane [2]. The core of the
translocase is formed by SecYEG which forms a large pore
through which proteins are transported [3]. SecA is a dimeric
ATPase bound to the cytoplasmic site of the pore actively
driving translocation of precursor proteins.
Proteins that have to be transported by this machinery are
synthesized with an N-terminal extension called the signal se-
quence. The N-terminus usually contains one to three basic
amino acid residues followed by a hydrophobic stretch of 10^
15 amino acid residues often containing a helix-breaking res-
idue near the center. The C-terminal part de¢nes the cleavage
site for leader peptidase, which allows removal of the signal
after translocation. The signal sequence is thought to insert
into the membrane via interactions with phospholipids [4]. In
the homologous eukaryotic translocation machinery crosslink-
ing experiments have demonstrated that the signal sequence is
in contact with phospholipids during translocation [5]. Re-
cently, it was demonstrated that the signal sequence in this
system binds to the translocase at the lipid^protein interface
[6].
SecA is the key component of the translocation machinery
interacting with almost all other components of the secretion
machinery. SecA binds to the E. coli inner membrane at high
a⁄nity binding sites consisting of SecYE protein and acidic
phospholipids [7]. Interaction with both acidic phospholipids
and the signal sequence stimulates its ATPase activity [8].
Upon arrival of precursors at the translocase SecA inserts in
the membrane pushing 20^30 amino acid residues to the other
side [9]. ATP hydrolysis allows deinsertion and completes the
cycle [10]. SecA contains two ATP binding sites per monomer
[11]. The N-terminal site (NDBI) binds ATP with high a⁄n-
ity. A mutation in this ATP binding site blocks SecA in the
membrane-inserted state [12,13]. The C-terminal ATP binding
site (nucleotide binding domain (NBD)II) binds ATP with low
a⁄nity. A mutation in this ATP binding site does not interfere
with the insertion-deinsertion cycle. However, NDBII is essen-
tial for translocation and translocation ATPase activity. This
suggests that NDBII couples SecA-membrane cycling to for-
ward movement of the precursor.
To investigate the role of the two ATP binding sites in the
SecA^precursor interaction we made use of the precursor of
the outer membrane pore protein PhoE containing single cys-
teines in either the signal sequence or the mature part of the
protein. These cysteines were modi¢ed with a photoactivat-
able crosslinker, whereafter the precursor^SecA interaction
was studied under a variety of conditions. UV irradiation of
mixtures containing these precursors and SecA and SecB re-
sulted in a nucleotide-dependent labeling of SecA. This inter-
action was una¡ected by the presence of E. coli phospholipids
but was prevented by phosphatidylglycerol. A mutation in the
high a⁄nity ATP binding domain of SecA interferes with the
nucleotide dependency of crosslinking demonstrating that this
site is involved in modulating the interaction with the precur-
sor.
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2. Materials and methods
SecA [14], SecB [15], phoE [16] and the prePhoE single-cysteine
mutant A-5C [17] were puri¢ed as described. Plasmid pNN105, a
derivative of pNN100 [17], in which the lysine codon 125 of prePhoE
is changed into a cysteine codon by site-directed mutagenesis, was
used to overexpress prePhoE K125C. prePhoE K125C was further
puri¢ed as described. Processing with puri¢ed leader peptidase was
done as described [18]. Protein concentrations were determined ac-
cording to [19]. Inverted inner-membrane vesicles were prepared
from E. coli strain MC4100 according to [20]. N-[4-(p-Azidosalicyl-
amido)butyl]-3P-(2P-pyridyldithio)propionamide (APDP) and iodogen
were obtained from Pierce chemical Co. (Rockford, IL, USA).
ATP, ADP, 5-adenylylimidodiphosphate (AMP-PNP) and 5,5P-di-
thio-bis(2-nitrobenzoic acid) (DTNB) were purchased from Sigma
chemical Co. (St. Louis, MO, USA). Na125I (IMS300, 350^600 mCi/
ml) was from Amersham (Buckinghamshire, UK). Sephadex G25 Col-
umns were from Pharmacia (Uppsala, Sweden). DOPG and DOPC
were from Avanti polar Lipids (Birmingham, AL, USA). E. coli phos-
pholipids were puri¢ed as described [21]. TID-maleimide tin-based
precursor TTD-maleimide was a kind gift of Dr. J. Brunner and
iodinated and conjugated as described [22]. All other chemicals were
of analytical grade or better.
2.1. Preparation of large unilamellar vesicles
A lipid ¢lm consisting of 0.5 Wmol of E. coli phospholipid, DOPC
or DOPG was dried under vacuum. Films were hydrated in 50 mM
HEPES^NaOH pH 7.9, 50 mM KCl and subsequently extruded
through a 400 nm polycarbonate ¢lter to obtain large unilamellar
vesicles [23].
2.2. Reduction of precursors prior to conjugation with APDP
100 Wg of each precursor was precipitated by addition of an equal
volume of 10% trichloroacetic acid (TCA). Pellets were washed with
ice-cold acetone and subsequently dissolved in 8 M Urea, 50 mM
Tris^HCl pH 7.9, 10 mM DTT and incubated at room temperature
for 30 min. Subsequently, the precursors were again precipitated with
10% TCA and washed with acetone. Pellets were now dissolved in 100
Wl 8 M urea, 50 mM Tris pH 7.9 and used immediately for conjuga-
tion.
2.3. Iodination of APDP and conjugation to prePhoE
In an iodogen-coated glass tube 0.75 Wl APDP in dimethylsulfoxide
(DMSO) (6 mg/ml), 6.7 Wl phosphate-bu¡ered saline (PBS) (20 mM
HPO4/H2PO4 pH 7.4, 150 mM NaCl) and 1 mCi of 125 I were com-
bined. After 2 min at room temperature, the reaction mixture was
transferred to an Eppendorf tube containing 1 Wl 100 mM unlabeled
NaI to prevent remaining radioactive iodine to react with the prepro-
tein. Subsequently, the freshly reduced precursor was added and al-
lowed to react with APDP for 1 h at room temperature. The
[125I]APDP-labeled precursors were separated from free label on a
Sephadex G25 gel¢ltration column eluted with 8 M urea, 50 mM
Tris^HCl pH 7.9. Fractions of 0.5 ml were collected and analyzed
by 10% sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and autoradiography.
2.4. Protein-translocation reactions
Reaction mixtures (50 Wl) contained SecA (20 Wg/ml), SecB (34 Wg/
ml), ATP (2 mM), and inner membrane vesicles (1 mg protein) in
translocation bu¡er (50 mM HEPES^KOH, pH 7.9, 30 mM KCl,
2 mM DTT, 20 mM MgAc, 100 WM DTNB). Sodium azide was
used at 10 mM concentration to inhibit translocation. Precursor pro-
teins were diluted 50-fold from a solution containing 8 M urea and
50 mM Tris^HCl, pH 7.9, and incubated in the reaction mixture at
37‡C for 20 min. 45 Wl of the reaction mixture was added to 1 Wl of
proteinase K (5 mg/ml) and incubated for 10 min on ice. Reactions
were stopped by the addition of an equal volume of 20% (w/v) TCA.
Samples were centrifuged for 10 min at 13 krpm in an Eppendorf
centrifuge, washed with acetone, and analyzed on 15% SDS^PAGE
[24]. DTNB was included in the reactions to prevent reduction of the
label [25]. Translocation ATPase assays were performed as described
[26].
2.5. Crosslinking reactions
SecA (20 Wg/ml), SecB (33 Wg/ml), labeled prePhoE (2 Wg/ml), phos-
pholipids (100 WM), azide (10 mM) and nucleotides (2 mM) as indi-
cated in the ¢gures were incubated in 50 Wl translocation bu¡er for 10
min at 37‡C. Subsequently, samples were irradiated for 5 min with a
15 W UV light source at V254 nm wavelength, precipitated by addi-
tion of an equal volume of 10% TCA and analyzed by SDS^PAGE
and autoradiography. For competition experiments unlabeled pre-
PhoE or mature PhoE diluted from 8 M urea/50 mM Tris^HCl pH
7.9 was included in the reaction mixture.
3. Results
To investigate the interactions between prePhoE and its
signal sequence with components of the Sec machinery, two
mutant proteins containing a cysteine in either the signal se-
quence or the mature part of the protein were puri¢ed (Fig.
1B). These precursors were modi¢ed with radioiodinated
APDP (Fig. 1A). The resulting labeled prePhoE could be
detected as a radioactive band by SDS^PAGE and autora-
diography (Fig. 1C). Treatment of the labeled precursors
with L-mercaptoethanol resulted in removal of more then
95% of the label demonstrating that most of the bound radio-
activity was derived from APDP conjugated via a disul¢de
Fig. 1. The structure of APDP (A), the single cysteine mutants used
(B), labeling of both mutants with [125I]APDP and removal of the
label after treatment with L-mercaptoethanol (L-ME) (C) and the
translocation activity of both mutants (D) 10% st represents 10% of
the material that was not treated with proteinase K.
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bridge (Fig. 1C). The labeled precursors were used in in vitro
translocation reactions using puri¢ed SecA, SecB and inverted
inner-membrane vesicles. Translocation of prePhoE-K125C
resulted in the appearance of two protease-protected bands
corresponding to precursor and mature PhoE (Fig. 1D).
Translocation of prePhoE-A-5C resulted in a protease-pro-
tected precursor band and a faint mature-sized band. In this
case, processing leads to removal of the radioactive label,
therefore the processed precursors can not be detected by
autoradiography. Processing was not abolished by the mod-
i¢cation of the signal sequence, since the labeled signal se-
quence could still be detected after in vitro processing with
puri¢ed leader peptidase (not shown). The low amount of
label in the mature-sized band was most likely derived from
some iodination in the mature part of the precursor. Trans-
location e⁄ciencies typically ranged from 60 to 90% for pre-
PhoE-K125C and 30 to 40% for A-5C. Together these data
demonstrate that [125I]APDP-modi¢ed prePhoE A-5C and
K125C are valid model proteins for studying interactions
with components of the translocation machinery.
These precursors were used to investigate the interaction
with SecA. Labeled prePhoE was incubated in the presence
or absence of a ¢ve-fold excess SecB tetramers to ensure op-
timal formation of the SecB^prePhoE complex [16,27] and in
the presence or absence of a ¢ve-fold excess of SecA dimers.
In the absence of SecB, prePhoE rapidly loses its translocation
competence [28]. Translocation of [125I]APDP-modi¢ed pre-
cursors was dependent on SecB as well (not shown). Samples
were irradiated and proteins were precipitated with TCA and
APDP was subsequently removed from prePhoE by addition
of sample bu¡er with L-mercaptoethanol. Crosslink products
contained only a covalently linked APDP moiety and there-
fore run with the same electrophoretic mobility on SDS^
PAGE gels. This resulted in labeling of a band with the elec-
trophoretic mobility of SecA irrespective whether the label
originated from the signal sequence or the mature part of
the precursor (Fig. 2). Surprisingly, no band was observed
at the position in the gel where SecB was present. This sug-
gests that the precursor, at the positions where the crosslinker
is attached, is not in direct contact with SecB. PrePhoE ap-
pears as a heavily labeled band.
SecA labeling occurred from both the signal sequence and
the mature part of the precursor protein. To get more infor-
mation on the speci¢city of the SecA labeling from the pre-
cursor, we investigated whether unlabeled precursor and ma-
ture PhoE were able to compete with the [125I]APDP-labeled
prePhoE. Inclusion of a 10-fold excess of unlabeled precursor
or mature PhoE both resulted in a strong reduction of the
labeling indicating that SecA does not require the signal se-
quence for prePhoE binding (Fig. 3).
In this experiment, labeling from the signal sequence also
resulted in the appearance of a faint 85 kDa band (Fig. 3).
This protein was apparently not separated from SecA in the
previous gel. This band was not dependent on addition of
other proteins, so it must be derived from a minor impurity
of the puri¢ed prePhoE-A-5C. This protein was most likely
labeled with APDP during the labeling of prePhoE and does
not lose all its label after irradiation and treatment with L-
mercaptoethanol. Since it was not a crosslink product it was
not further characterized.
Crosslinking from both the signal sequence and the mature
domain was dependent on the presence of nucleotides. Addi-
tion of 2 mM ATP almost completely inhibited SecA labeling
(Fig. 4). Addition of 2 mM ADP and phosphate also inhibited
the SecA labeling. Addition of 2 mM AMP-PNP a non-hy-
drolyzable ATP analogue resulted in strong labeling of SecA.
Apparently, ATP-bound SecA has a high a⁄nity for the pre-
cursor which is strongly reduced under ADP-bound condi-
tions.
Azide is a strong inhibitor of translocation and ATPases in
general and leads to complete block in translocation of the
labeled precursors (Fig. 5A) [29]. Therefore, we analyzed the
crosslinking reactions in the absence and presence of 10 mM
azide. Surprisingly, even in the presence of 10 mM azide ATP
Fig. 2. Crosslinking of SecA with prePhoE K125C or A-5C in the
presence or absence of SecA and SecB as indicated, analyzed by
15% SDS^PAGE and autoradiography.
Fig. 3. Labeling of SecA in the presence or absence of competing
precursor (20 Wg/ml) or mature PhoE (20 Wg/ml).
Fig. 4. Crosslinking of prePhoE to SecA in the presence or absence
of nucleotides. Quanti¢cations were done using molecular dynamics
Image QuaNT software and represent the mean of two experiments.
Error bars represent the standard deviation.
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was still able to reduce the labeling e⁄ciency of SecA (Fig.
5B).
SecA contains two ATP binding sites which di¡er in their
a⁄nity for ATP [11]. To get insight into which binding site
was involved in modulating the SecA^precursor interaction,
we puri¢ed two mutants SecAD209N and SecAR509K which
contain mutations in NDBI (high a⁄nity) and NDBII (low
a⁄nity) respectively, resulting in an inability to bind ADP at
the mutated binding site [11]. Both mutants displayed no
translocation ATPase activity and did not support protein
translocation (not shown). Crosslinking reactions in the pres-
ence of SecAD209N resulted in labeling irrespective of the
presence of ATP (Fig. 6). Crosslinking in the presence of
SecAR509K also results in labeling of the SecA mutant. Ad-
dition of ATP reduced the amount of labeling to 35^50%
indicating that binding and hydrolysis of ATP at NBD I is
modulating the interaction with the precursor protein.
SecA inserts in phospholipid mono- and bilayers in a nu-
cleotide-dependent way [30,31]. Furthermore, both the signal
sequence and the mature domain interact with phospholipid
monolayers [4,16]. Therefore, we were interested whether
phospholipids a¡ected the SecA^precursor interaction. First,
SecA, SecB and prePhoE were incubated for 10 min to estab-
lish complex formation then liposomes were added and the
mixtures were further incubated for another 5 min before
photolysis. Addition of liposomes consisting of pure DOPG
led to a strong reduction of the crosslink as compared to the
situation without vesicles (Fig. 7). Addition of ATP in the
presence of DOPG liposomes still had a small reducing e¡ect
on the crosslink e⁄ciency. Addition of liposomes composed of
the zwitterionic DOPC or puri¢ed E. coli phospholipids did
not a¡ect the crosslinking with SecA. This demonstrates that
the presence of E. coli phospholipids does not disturb the
complex, whereas highly charged membranes loosen the
SecA^precursor interaction. Crosslinks between the precursor
and phospholipids could not be detected. Arylazide-based
photocrosslinkers like APDP tend to undergo rapid intra mo-
lecular ring expansion after photoactivation and are therefore
less reactive with lipid acyl-chains [32]. Using a carbene-gen-
erating reagent it was shown that the signal sequence interacts
with phospholipids during translocation [5]. Modi¢cation of
prePhoE A-5C with [125I]TID-maleimide [22], containing a
similar reactive group, abolished translocation activity and
could therefore not be used.
4. Discussion
To investigate the interaction between the precursor and
components of the translocation machinery in more detail
we made use of two prePhoE single cysteine mutants. One
with a cysteine in the signal sequence and one with a cysteine
in the mature part of the protein. These precursors were la-
beled with the photoactivatable crosslinker APDP. In in vitro
translocation experiments these modi¢ed precursors behaved
like wild type prePhoE. Therefore, these proteins could be
used to assess interactions between prePhoE and other com-
ponents during the translocation process.
Surprisingly, labeling of SecB was not observed under con-
ditions that result in formation of the SecB^prePhoE complex.
This may indicate that both the signal sequence and the res-
Fig. 5. Translocation of [125I]APDP modi¢ed precursors is inhibited
in the presence of azide (A) 10% st represents 10% of the material
that was not treated with proteinase K. Azide does not in£uence
the ATP modulated interaction with the precursor (B).
Fig. 6. Crosslinking of prePhoE with SecA, SecAD209N and Sec-
AR509K in the presence of ATP (A). Quantitative analysis of the
autoradiograms of three experiments (B). The relative level of label-
ing in the presence of ATP is plotted respective to the level of label-
ing in the absence of ATP. Error bars represent the standard devia-
tion.
Fig. 7. Crosslinking of prePhoE in the presence of liposomes com-
posed of di¡erent types of phospholipids. SecA, SecB and
[125I]APDP-labeled prePhoE where incubated in translocation bu¡er
and subsequently liposomes were added. Samples were photolysed
and treated as described in Section 2.
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idues around residue 125 do not directly interact with SecB.
Interaction between SecB and prePhoE was suggested to oc-
cur via L-structures [27]. Residue 125 is part of a loop and
may therefore not be in direct contact with SecB. Further-
more, residue 125 was not reported to be part of the SecB
binding frame which is located in four parts, namely residues
25^93, 129^174, 204^250, and 316^330 of the mature part of
the precursor [33].
SecA was clearly labeled from both the signal sequence and
the mature domain of prePhoE. Crosslinking was markedly
reduced after addition of either ATP or ADP and phosphate,
the products of ATP hydrolysis. Addition of the non-hydro-
lyzable ATP analogue AMP-PNP did not result in a reduction
of SecA labeling. This indicates that SecA in the ADP-bound
form is no longer in close proximity of the APDP-moiety
suggesting that ADP-bound SecA has a less tight interaction
with the precursor. To discriminate which of the two ATP
binding sites was involved in changing the interaction with
prePhoE we made use of two SecA ATP binding site mutants.
The mutant in the high a⁄nity ATP binding site showed no
response to ATP addition. Therefore, it was concluded that
this site was involved in modulating the precursor interaction.
SecA consists of two independently folding domains [34].
The N-terminal domain contains both ATP binding sites and
the precursor binding site [35]. The C-domain regulates the
SecA ATPase activity by binding to the N-domain [36]. Bind-
ing of ADP leads to formation of a more compact conforma-
tion [34]. We demonstrate that the ADP-bound conformation
has a less tight interaction with prePhoE then the ATP-bound
conformation. Possibly, the precursor binding site is buried in
the more compact conformation of the N-domain. Alterna-
tively, the precursor binding site may be inaccessible by bind-
ing of the C-domain [36].
Azide is a very potent inhibitor of protein translocation
[29]. The ATP-dependent change in interaction between pre-
PhoE and SecA, however, was not inhibited in the presence of
azide. Similarly also the nucleotide-dependent insertion of
SecA into phospholipid monolayers was una¡ected by the
presence of azide [30]. SecA was shown to possess some re-
maining ATPase activity in the presence of azide [37]. This
remaining activity may be enough for SecA to acquire an
ADP-bound conformation during the timescale of the experi-
ment, and thereby loosen its interaction with the precursor.
A synthetic signal peptide was shown to enhance SecA-lipid
ATPase activity of E. coli phospholipids [8]. Furthermore,
interaction between SecA and a signal sequence promoted
SecA insertion into the bilayer [38]. This suggests that SecA
and the signal sequence co-insert into the bilayer. In the pres-
ence of liposomes composed of E. coli phospholipids the nu-
cleotide-dependent interaction between SecA and the signal
sequence was still found. This demonstrates that in the natural
lipid environment the SecA^precursor interaction is main-
tained. However, crosslinking in the presence of phospholipid
vesicles composed of pure negatively-charged DOPG reduced
the crosslinking between SecA and prePhoE, demonstrating
that the presence of a high amount of negative charges at the
membrane surface disrupts the complex. Inner-membrane
vesicles of E. coli strains unable to synthesize PE contain a
high concentration of the acidic phospholipids PG and cardi-
olipin [21,39]. Our results suggest that under these conditions
the SecA^precursor interaction would be disturbed which
could compromise translocation in this strain. This suggestion
is supported by the observation that SecA expression is in-
creased, apparently to compensate for a reduced translocation
e⁄ciency [39].
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